Skip to content

Durham, North Carolina

ISO consultants for Durham drug, device and lab companies.

Lilly's Durham County site fills and assembles drug delivery devices. FDA's combination product rule now spells out the device side in ISO 13485 clauses. No certificate is required; a system that meets those clauses is.

ISO certification consulting in Durham at a glance

Who we are
Glocal Insight: senior ISO management system consultants working with Durham companies on site and remotely. The consultant who scopes the work does the work.
Standards
ISO 9001, AS9100, ISO 14001, ISO 45001, ISO 27001, ISO 42001, ISO 13485, ISO 17025, plus internal audits, auditor training and ISO certification maintenance.
Typical timeline
For ISO 9001 at a company of 10 to 100 people, about three to four months from kickoff to the Stage 2 audit. Week by week.
Cost
A standalone gap analysis is typically in the low five figures; full implementation depends on scope. Certification body fees are separate. How certification costs are set, or estimate your audit days.
Track record
100% certification success. 100% of surveyed clients would recommend us.
Contact
(816) 535-0738 or start a conversation.

Where drug manufacturing meets ISO 13485

The Durham-Chapel Hill metropolitan area is four counties: Durham, Orange and Chatham, with Person as an outlying county. It has 356 manufacturing establishments, 312 of them with fewer than 100 employees — about 88% of the base — employing about 25,750 people (US Census County Business Patterns, 2023). Pharmaceutical and medicine manufacturing employs about 6,380 people here, at 8.3 times the national concentration and more than one manufacturing job in five, and research and development in the physical, engineering and life sciences adds about 8,900 jobs at 7.3 times (BLS QCEW, 2024 annual averages).

More of that drug manufacturing now ends in a device. Eli Lilly's Research Triangle Park site, in Durham County, was announced in 2020 to make injectable products and delivery devices, and a $450 million expansion adds capacity for device filling, device assembly and packaging, starting with Trulicity and Mounjaro.

A drug delivered in a device is a combination product, and FDA does not make the plant that makes it run two complete quality systems. Under 21 CFR 4.4, a plant whose operating system already complies with the drug good manufacturing practice rules shows device compliance through a short list of added requirements.

Since February 2, 2026, when FDA's Quality Management System Regulation took effect, that list is written in ISO 13485 clause numbers: management responsibility, design and development, purchasing, data analysis and complaint handling, installation and servicing. FDA does not require an ISO 13485 certificate for any of it. What it requires is a system that demonstrably meets those clauses.

Industry in Durham

  • Eli Lilly, Research Triangle Park Durham County site announced in 2020 for injectable products and delivery devices; a $450 million expansion adds device filling, device assembly and packaging capacity.
  • Biogen, Research Triangle Park $2 billion investment announced July 2025, including clinical and commercial fill-finish, across campuses in Durham and Wake counties.
  • Merck, Durham $1 billion, 225,000-square-foot vaccine manufacturing facility opened at its Durham site in 2025.
  • Bioventus Medical device company headquartered in Durham: pain treatments, fracture treatments and surgical products.
  • Pharmaceutical and medicine manufacturing About 6,380 jobs at 8.3 times the national concentration, more than one manufacturing job in five (BLS QCEW, 2024).

What 21 CFR 4.4(b)(1) now lists

When a combination product has a device constituent part and a drug constituent part, and the plant's system has been shown to comply with the drug rules, the regulation says “the following clauses of ISO 13485 (together with the definitions in Clause 3 of ISO 9000), and certain other provisions within the QMSR must also be shown to have been satisfied.” There are six:

General requirements and management responsibility: clause 4.1, clause 5 and its subclauses, clause 6.1, and the QMSR's own section 820.10. Design and development: clause 7.3 and its subclauses. Purchasing: clause 7.4 and its subclauses. Analysis of data, improvement and complaint handling: clauses 8.2.2, 8.4 and 8.5, with the records rule in 820.35(a). Installation: clause 7.5.3. Servicing: clause 7.5.4, with 820.35(b).

FDA describes these as conforming edits and says they do not change the good manufacturing practice requirements for combination products. That is the right way to read them. The obligations are the same; the vocabulary is new. A drug-side quality team that learned the old Part 820 section numbers now answers in ISO 13485 clauses, and an inspector reading your procedures will expect to find them there.

For a drug-led plant, design and development often needs the most new work: where the device was designed elsewhere, its design records still have to be controlled, transferred and kept current under your system. Purchasing is the one that reaches the supply chain.

Which rule applies depends on where the parts come together

Part 4 draws its lines by facility, and the lines decide what a Triangle supplier owes.

Where the drug and device parts meet in one facility, the streamlined route applies, and the regulation says it may begin once both types of constituent part have arrived at, or are being made in, the same facility. That is the drug-led plant with its six ISO 13485 additions.

Where a constituent part is made at a separate facility, that facility's system has to comply with all of the good manufacturing practice requirements for that type of part. A plant that makes only the device constituent part is held to the full device rule, which since February 2026 means a quality management system that complies with the applicable requirements of ISO 13485.

Where a plant's system is device-based, the route runs the other way: it adds named drug rules instead, among them component testing, expiration dating, testing and release, stability testing and reserve samples.

And a component supplier is outside the device rule altogether. The QMSR does not apply to manufacturers of components or parts of finished devices. A molder or machinist supplying a housing or a spring meets its requirements through the customer's purchasing controls, which for a drug-led plant now means clause 7.4 of ISO 13485. Expect supplier questionnaires and audits written in that language.

Certificates, inspections and what to buy

FDA has said plainly that it will not require certificates of conformance to ISO 13485, and that a certificate will not exempt a manufacturer from an FDA inspection. On February 2, 2026 it also stopped using its old Quality System Inspection Technique and moved to a new inspection process.

So for a drug-led plant the question is not certification. It is whether your system, written for drug rules, can show an inspector the six ISO 13485 additions working: design files under control, supplier evaluation tied to risk, complaint and data analysis feeding corrective action. A gap assessment against those clauses is the right first purchase.

For a supplier, the answer is often different. A customer qualifying you under clause 7.4 needs evidence, and an accredited ISO 13485 certificate, or ISO 9001 where the customer accepts it, is frequently the cheapest evidence to give. Medical device makers are here too: Bioventus, a device company making pain treatments, fracture treatments and surgical products, is headquartered in Durham, and electromedical apparatus manufacturing runs at more than twice the national concentration (BLS QCEW, 2024).

The laboratory side of the Triangle

The research and development figure is the other half of this economy: 218 establishments and about 8,900 jobs in physical, engineering and life sciences research, at more than seven times the national concentration (BLS QCEW, 2024).

Part 4's drug-side list for device-led plants includes testing and release, stability testing and special testing requirements, and some of that testing can be done by contract laboratories rather than the manufacturer. Where a customer or sponsor asks a laboratory for accredited results, ISO/IEC 17025 is the credential. Laboratories are accredited, not certified, by an accreditation body such as A2LA or ANAB, and the scope of accreditation decides which tests and methods the credential covers.

One geographic note: Research Triangle Park straddles Durham and Wake counties, and Biogen's own release places its park campuses in both. Wake County belongs to the Raleigh metro. The counts on this page cover Durham, Orange, Chatham and Person counties only.

How we work with companies here

We work with Durham companies on site and remotely, and we put the on-site days where being in the building changes the outcome: the gap assessment walkthrough, the first internal audit cycle and the certification or pre-inspection audits.

For a drug-led plant, the first meeting is usually a mapping exercise: your existing drug quality procedures laid against the six ISO 13485 additions in 21 CFR 4.4(b)(1), so the gaps are named by clause before anyone writes a new procedure. For a supplier, it starts with the customer's supplier quality agreement and questionnaire.

The consultant who scopes the engagement does the work. No handoff to a junior implementer after the sale.

100% certification success. Every client we have taken to a Stage 2 certification audit has been certified, with no major nonconformities. 100% of surveyed clients would recommend us. Every client who answered our client satisfaction survey said they would recommend Glocal Insight.

ISO standards we help Durham companies with

This page focuses on ISO 13485, and we can help Durham companies with any of the standards below. If you are deciding whether to bring in outside help, start with what an ISO consultant does, how fees work and when certification is worth it.

ISO 13485 in Durham

The Durham-Chapel Hill metro has 29 medical equipment and electromedical device manufacturing establishments (BLS QCEW, 2024 annual averages). ISO 13485 is the quality management standard for medical devices, and since February 2, 2026 the FDA's Quality Management System Regulation incorporates it by reference.

The focus of this page. ISO 13485 consultants → · Free ISO 13485 internal audit checklist · ISO 13485 audit days calculator

ISO 9001 in Durham

The Durham-Chapel Hill metro has 356 manufacturing establishments, 312 of them with fewer than 100 employees (US Census County Business Patterns, 2023), and 458 durable-goods wholesalers (BLS QCEW, 2024 annual averages). ISO 9001 is the most widely held ISO management system certification and the base that AS9100, ISO 13485 and the other sector standards build on.

ISO 9001 consultants → · Free ISO 9001:2026 gap analysis checklist · Free ISO 9001 internal audit checklist

ISO 17025 in Durham

The Durham-Chapel Hill metro has 30 testing laboratories (BLS QCEW, 2024 annual averages). ISO/IEC 17025 is the accreditation standard for testing and calibration laboratories, including in-house labs whose results customers or regulators rely on.

ISO 17025 consultants →

AS9100 in Durham

The Durham-Chapel Hill metro has 3 aerospace product and parts establishments and 19 machine shops (BLS QCEW, 2024 annual averages). AS9100 adds aerospace requirements to ISO 9001, and it reaches machine shops and processors through the purchase orders of the aerospace companies they supply; distributors use AS9120.

AS9100 consultants → · Free AS9100 internal audit checklist

ISO 14001 in Durham

The Durham-Chapel Hill metro has 76 establishments in chemical, plastics and rubber, paper, primary metal, and metal coating and finishing manufacturing (BLS QCEW, 2024 annual averages), the industries where air, water and waste obligations tend to be heaviest. ISO 14001 gives a site one system for its permits, its environmental aspects and its customers' sustainability questionnaires.

ISO 14001 consultants → · Free ISO 14001:2026 gap analysis checklist · Free ISO 14001 internal audit checklist

ISO 45001 in Durham

The Durham-Chapel Hill metro has 356 manufacturing establishments (US Census County Business Patterns, 2023) and 1,600 construction establishments (BLS QCEW, 2024 annual averages). ISO 45001 turns a safety program into a management system, with hazard identification, worker participation and incident follow-up that a customer, general contractor or insurer can check.

ISO 45001 consultants →

ISO 27001 in Durham

The Durham-Chapel Hill metro has 1,540 computer systems design, software publishing and hosting establishments (BLS QCEW, 2024 annual averages). ISO 27001 is the internationally recognized certification for an information security management system, and a common answer to enterprise customers' security questionnaires.

ISO 27001 consultants → · Free ISO 27001 internal audit checklist · ISO 27001 audit days calculator

ISO 42001 in Durham

The Durham-Chapel Hill metro has 905 software publishers and custom programming firms (BLS QCEW, 2024 annual averages). ISO/IEC 42001 is the management system standard for organizations that develop or use AI, and it fits alongside an existing ISO 27001 system. See which state AI laws reference it.

ISO 42001 consultants →

What an engagement covers

  • Part 4 gap assessment Your drug quality system mapped against clauses 4.1, 5, 6.1, 7.3, 7.4, 7.5.3, 7.5.4, 8.2.2, 8.4 and 8.5 of ISO 13485 and the cited QMSR sections, with each gap named.
  • ISO 13485 system build A full quality management system for device makers and separate-facility constituent part makers, written to the QMSR. See ISO 13485.
  • Design control for drug-led teams Design and development files, transfer and change control set up so a pharmaceutical quality team can run and defend them.
  • Supplier qualification under clause 7.4 Risk-based supplier evaluation, quality agreements and monitoring, built for the supply chain behind a combination product.
  • ISO/IEC 17025 for contract labs Scope-first accreditation work for testing laboratories serving Triangle manufacturers. See ISO/IEC 17025.
  • Internal audit and management review Auditor-grade internal audits against the clauses an FDA investigator will read, and a management review that records decisions.

Questions we get from companies in this market

Does a Durham drug plant making a combination product need ISO 13485 certification?

No regulation requires it. FDA says it will not require certificates of conformance to ISO 13485, and a certificate does not exempt a plant from inspection. What 21 CFR 4.4(b)(1) requires of a plant whose system complies with the drug rules is a showing that named ISO 13485 clauses are satisfied: management responsibility, design and development, purchasing, data analysis and complaint handling, installation and servicing. A certificate is a business decision, often driven by customers or other markets.

What changed for combination products on February 2, 2026?

The Quality Management System Regulation took effect, and FDA made conforming edits to Part 4 so that its streamlined device list now cites ISO 13485 clauses and a few QMSR sections instead of the old Part 820 sections. FDA says the edits do not change the good manufacturing practice requirements for combination products. In practice the obligations are the same, but procedures and inspection answers should now be framed in ISO 13485 terms.

We mold parts for a Triangle injectable device line. Does the QMSR apply to us?

Usually not directly. The QMSR does not apply to manufacturers of components or parts of finished devices. Your requirements arrive through your customer's purchasing controls, which for a drug-led combination product plant are now framed by clause 7.4 of ISO 13485. If instead you make a whole device constituent part at your own facility, Part 4 holds that facility to the full device rule.

Our lab tests for Triangle drug makers. Do we need ISO/IEC 17025?

Only if your customers or sponsors ask for accredited results. Laboratories are accredited to ISO/IEC 17025, not certified, by an accreditation body such as A2LA or ANAB. The scope of accreditation lists the tests and methods covered, so build it around the work your customers actually send you.

Is Research Triangle Park in the Durham metro?

Partly. The park straddles Durham and Wake counties. The Durham County side is in the Durham-Chapel Hill metropolitan area, with Orange, Chatham and Person counties; the Wake County side belongs to the Raleigh metro. Companies with campuses on both sides, as Biogen has, sit in both.

How many manufacturers are in the Durham-Chapel Hill metro?

On the federal metropolitan definition, 356 manufacturing establishments, 312 of them with fewer than 100 employees, employing about 25,750 people (US Census County Business Patterns, 2023). Pharmaceutical and medicine manufacturing alone employs about 6,380 people at 8.3 times the national concentration (BLS QCEW, 2024 annual averages).